Phase 2 Myeloma, Multiple Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Myeloma, Multiple
M.D. Anderson Cancer Center94 enrolled1 locationNCT05091372
Recruiting
Phase 2
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
MyelomaMyeloma, Multiple
AHS Cancer Control Alberta100 enrolled2 locationsNCT04268199
Recruiting
Phase 2
Limited-duration Teclistamab
Myeloma, Multiple
Abramson Cancer Center at Penn Medicine75 enrolled5 locationsNCT05932680
Recruiting
Phase 1Phase 2
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
AML (Acute Myelogenous Leukemia)B-ALLMyeloma, Multiple+3 more
Tianjin Medical University General Hospital90 enrolled1 locationNCT06911710